KHAPZORY

Acrotech Biopharma Llc

Application Filed: 2018-10-23

Trademark Application Details

Mark For: KHAPZORY® trademark registration is intended to cover the categories of pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists. [all]

Status

2021-05-26 UTC

LIVE REGISTRATION Issued and Active

The trademark application has been registered with the Office.

Research	OneLook Acronym Finder
Serial Number	88165625
Registration Number	5898750
Mark Literal Elements	KHAPZORY
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2019-09-25
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Louis C. Cullman
Attorney Docket Number	1959396
Law Office Assigned	N40
Employee Name	GOODWIN, KATRINA JOYE

Timeline

2018-10-23	Application Filed
2018-12-10	Date of First Use
2018-12-10	Date of Use In Commerce
2019-01-15	Published
2019-01-15	Published for Opposition
2019-09-25	Location: PUBLICATION AND ISSUE SECTION
2019-10-29	Status: Live/Registered
2019-10-29	Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-10-29	Trademark Registered
2019-10-29	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	ACROTECH BIOPHARMA LLC
Address	279 PRINCETON HIGHTSTOWN ROAD EAST WINDSOR, NEW JERSEY UNITED STATES 08520
Legal Entity Type	Limited Liability Company
Legal Entity State	DELAWARE

Documents

Drawing	JPEG	2018-10-23
TEAS RF New Application	MULTI	2018-10-23
XSearch Search Summary	APPLICATION/XML	2018-12-08
Public Note	PDF	2018-12-11
TRAM Snapshot of App at Pub for Oppostn	MULTI	2018-12-12
Notice of Publication	XML	2018-12-26
Notification Of Notice of Publication	XML	2018-12-26
OG Publication Confirmation	APPLICATION/XML	2019-01-15
Notice of Allowance	XML	2019-03-12
Specimen	JPEG	2019-08-27
Statement of Use	MULTI	2019-08-27
ITU Unit Action	MULTI	2019-09-24
Notice of Acceptance of Statement of Use	XML	2019-09-26
TRAM Snapshot of App at Pub for Oppostn	MULTI	2019-09-26
Registration Certificate	PDF	2019-10-29

Attorney of Record

LOUIS C. CULLMAN
K&L GATES LLP
1 PARK PLAZA, 12TH FLOOR
IRVINE, CA 92614

Good, Services, and Codes

IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists. FIRST USE: 20181210. FIRST USE IN COMMERCE: 20181210

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists
GS0051	Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists

Trademark Filing History

Description	Date	Proceeding Number
REGISTERED-PRINCIPAL REGISTER	2019-10-29
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED	2019-09-26
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	2019-09-25
STATEMENT OF USE PROCESSING COMPLETE	2019-09-23	71906
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2019-09-20	71906
USE AMENDMENT FILED	2019-08-27	71906
TEAS STATEMENT OF USE RECEIVED	2019-08-27
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2019-06-05
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2019-03-12
PUBLISHED FOR OPPOSITION	2019-01-15
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-01-15
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2018-12-26
APPROVED FOR PUB - PRINCIPAL REGISTER	2018-12-11
ASSIGNED TO EXAMINER	2018-12-06	93051
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2018-11-04
NEW APPLICATION ENTERED IN TRAM	2018-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.